Evidence map›Paper›PMID 38062251›Full record

ArticleNature reviews. Cancer2024

Targeting cancer cell dormancy.

Judith Agudo, Julio A Aguirre-Ghiso, Mickie Bhatia, Lewis A Chodosh, Ana Luísa Correia, Christoph A Klein

Abstract read
In one paragraph

Article in Nature reviews. Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Metastasis in biological time.Frontiers in cell and developmental biology · 2026
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Judith AgudoDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA. Judith_Agudo@DFCI.HARVARD.EDU.ORCID http://orcid.org/0000-0002-3576-3169
Julio A Aguirre-GhisoDepartment of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, USA. julio.aguirre-ghiso@einsteinmed.edu.ORCID http://orcid.org/0000-0002-6694-6507
Mickie BhatiaFaculty of Health Sciences, McMaster University, Hamilton, ON, Canada. mbhatia@mcmaster.ca.ORCID http://orcid.org/0000-0002-9304-5130
Lewis A ChodoshDepartment of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. chodosh@pennmedicine.upenn.edu.
Ana Luísa CorreiaChampalimaud Research, Champalimaud Foundation, Lisbon, Portugal. analuisa.correia@research.fchampalimaud.org.ORCID http://orcid.org/0000-0003-2414-0131
Christoph A KleinExperimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany. christoph.klein@klinik.uni-regensburg.de.ORCID http://orcid.org/0000-0001-7128-1725

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI STEVEN C. ALMO · 1985 to 2026
$111.2M
Functional Determinants of Metastatic DormancyR01CA109182 · NCI · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI AGUIRRE-GHISO, JULIO A. · 2005 to 2025
$8.3M
Mechanisms of uveal melanoma dormancy and targeted therapy toleranceR01CA253977 · NCI · THOMAS JEFFERSON UNIVERSITY · PI AGUIRRE-GHISO, JULIO A., APLIN, ANDREW ERIC · 2020 to 2024
$2.4M
NCI NIH HHS P30 CA013330NCI NIH HHS R01 CA109182NCI NIH HHS R01 CA253977
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NeoplasmsCell Line, TumorCell ProliferationHumans

Identifiers

PMID38062251
PMCPMC11038906

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.